Get the Stockscreener App
4.86
3.62%
0.17
Nuvation Bio Inc stock is traded at $4.86, with a volume of 11.44M.
It is up +3.62% in the last 24 hours and up +36.90% over the past month.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
See More
Previous Close:
$4.69
Open:
$4.57
24h Volume:
11.44M
Relative Volume:
1.52
Market Cap:
$1.66B
Revenue:
-
Net Income/Loss:
$-75.80M
P/E Ratio:
-13.89
EPS:
-0.35
Net Cash Flow:
$-68.07M
1W Performance:
+2.75%
1M Performance:
+36.90%
6M Performance:
+123.96%
1Y Performance:
+69.34%
1-Day Range:
$4.53
$5.35
1-Week Range:
$4.53
$5.35
52-Week Range:
$1.54
$5.55
Nuvation Bio Inc Stock (NUVB) Company Profile
Name
Nuvation Bio Inc
Sector
Industry
Phone
(415) 754-3517
Address
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Compare NUVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
4.86 | 1.61B | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.15 | 110.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
693.50 | 73.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.16 | 59.98B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.98 | 54.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.22 | 40.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-30-25 | Initiated | Jefferies | Buy |
| Apr-23-25 | Initiated | Citizens JMP | Mkt Outperform |
| Mar-27-24 | Upgrade | Jefferies | Hold → Buy |
| Mar-26-24 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-06-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-02-22 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Aug-02-22 | Downgrade | BTIG Research | Buy → Neutral |
| May-04-22 | Initiated | H.C. Wainwright | Buy |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Apr-06-21 | Initiated | RBC Capital Mkts | Outperform |
| Mar-08-21 | Initiated | BMO Capital Markets | Outperform |
| Mar-08-21 | Initiated | BTIG Research | Buy |
| Mar-08-21 | Initiated | Cowen | Outperform |
| Mar-08-21 | Initiated | Jefferies | Buy |
| Mar-08-21 | Initiated | Wedbush | Outperform |
View All
Nuvation Bio Inc Stock (NUVB) Latest News
Is Nuvation Bio Inc. Warrants stock a defensive play amid uncertaintyWatch List & Real-Time Volume Trigger Notifications - newser.com
Will Nuvation Bio Inc. Warrants stock benefit from mergersQuarterly Earnings Report & Technical Pattern Recognition Alerts - newser.com
Is Nuvation Bio Inc. stock reversal real or fake2025 Historical Comparison & Stock Portfolio Risk Management - newser.com
Is Nuvation Bio Inc. stock recession proofJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - newser.com
Can Nuvation Bio Inc. stock maintain operating margins2025 Technical Patterns & Safe Entry Momentum Stock Tips - newser.com
How Nuvation Bio Inc. stock reacts to inflationary pressuresJuly 2025 Chart Watch & Safe Entry Point Identification - newser.com
Will Nuvation Bio Inc. Class stock profit from AI boomQuarterly Trade Report & Verified Momentum Stock Alerts - newser.com
What data driven models say about Nuvation Bio Inc.’s futureGold Moves & Short-Term Trading Alerts - newser.com
Nuvation Bio Surges as Q3 Revenue Beats, Price Target Raised - StocksToTrade
Is Nuvation Bio Inc. stock overvalued by current metricsJuly 2025 Big Picture & AI Enhanced Trading Alerts - newser.com
Can you recover from losses in Nuvation Bio Inc.Dividend Hike & Consistent Profit Trading Strategies - newser.com
Nuvation Bio’s Price Target Raised Amid Positive Q3 Earnings - timothysykes.com
What candlestick patterns are forming on Nuvation Bio Inc.Weekly Risk Summary & Short-Term Swing Trade Alerts - newser.com
Real time pattern detection on Nuvation Bio Inc. stockRate Cut & Technical Pattern Recognition Alerts - newser.com
How big funds are accumulating Nuvation Bio Inc. Warrants stockBreakout Watch & Verified Technical Trade Signals - newser.com
Published on: 2025-11-16 00:20:53 - newser.com
JMP Maintains “Market Outperform” on Nuvation (NUVB) for IBTROZI Launch Plans - MSN
Can Nuvation Bio Inc. stock deliver surprise earnings beatJuly 2025 Outlook & Long Hold Capital Preservation Plans - newser.com
Nuvation Bio Inc Stock (NUVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):